When best practice is bad medicine: A new approach to rationing tertiary health services in South Africa

South African Medical Journal

Volumn 98, Issue 5, 2008, Pages 350-356

  Kenyon, Chris ^a   Ford, Nathan ^b   Boulle, Andrew ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRETROVIRUS AGENT; BCG VACCINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RIVASTIGMINE;

ALZHEIMER DISEASE; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG MARKETING; GOOD CLINICAL PRACTICE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; ISCHEMIC HEART DISEASE; MEDICAL EDUCATION; NATIONAL HEALTH SERVICE; PATIENT CARE; PRIMARY HEALTH CARE; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION; SOCIOECONOMICS; SOUTH AFRICA; TERTIARY HEALTH CARE; TUBERCULOSIS;

COST CONTROL; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HEALTH CARE RATIONING; HUMANS; SOUTH AFRICA;

EID: 44649196753     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Healthcare 2010: Health Western Cape's Plan for Ensuring Equal Access to Quality Health Care. Cape Town: Department of Health, Western Cape, 2003. www.capegateway.gov.za/ Text/2005/7/ cover_contents∀reward.pdf (accessed 10 December 2007).
2. Mayosi B. 2007. Briefing by Prof. Bongani Mayosi on challenges facing Health Care in the Western Cape. http://www.pmg.org.za/schedule/ audio.htm (accessed 10 November 2007).
3. World Health Report 2000. Health Systems: Improving Performance. Geneva: World Health Organization, 2000.
4. Poullier J, Hernandez P, Kawabata K, Savedoof WD. 2002 Patterns of Global Health Expenditures: Results for 191 Countries. Geneva: WHO, 2002. http://www.who.int/healthinfo/paper51.pdf (accessed 12 November 2007).
5. Day C, Gray A. Health and related indicators. In: Ijumba P, Barron P, eds. South Afirican Health Review 2005. Durban Health Systems Trust, 2005.
6. Evans R, Marmor T, Barer M. Why Are Some People Healthy and Others Not? The Determinants of the Health of Populations. New York Aldine, 1994.
7. World Health Report 2006: Working Together for Health. Geneva: World Health Organization, 2006.
8. McIntyre D, Bloom G, Doherty J, Brijal P. 1995 Health Expenditure and Finance in South Africa. In: Handson D, ed. South African Health Review 1995. Durban: Health Systems Trust, 1995.
9. Comprehensive Service Plan for the Implementation of Healthcare 2010. Cape Town: Western Cape ProvincLal Department of Health, 2006. www.capegateway.gov.za/eng/pubs/public_info/ C/143710 (accessed 10 November 2007).
10. Mills A. The economics of hospitals in developing countries - Part II: Costs and sources of income. Health Policy and Planning 1990; 5(3): 203-218.
11. Schieber GJ. Health expenditures in major industrialized countries, 1960-1987. Health Care Financing Review 1990; 11:159-168
12. Scherer FM. The pharmaceutical industry - prices and progress. N Engl J Med 2004,351:927-932.
13. Médecins Sans Frontières. Untangling the web of price reductions: a pricing guide for the purchase of antiretroviral drugs for developing countries. 10th ed. July 2007. www. accessmed-msf.org/ resources/key-publications (accessed 10 December 2007).
14. Mills A. The economics of hospitals in developing countries - Part I: Expenditure patterns. Health Policy and Planning 1990; 5(2):107-117.
15. Tan-Torres E, Baltussen R, Adam T, eds. Making Choices in Health: WHO Guide to Cost Effectiveness Analysis. Geneva WHO, 2003.
16. Henry DA, Hill SR, Harris A. Drug prices and value for money: The Australian Pharmaceutical Benefits Scheme. JAMA 2005; 294:2630-2632.
17. Claxton K, Buxton M, Cuyle A, Walker S, Schupher M. Value based pricing for NHS drugs: an opportunity not to be missed? BMJ 2008; 336: 251-254.
18. Mendis S, Fukino K, Cameron A. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 2007; 85(4): 279-288.